0468: Monocentric experience of drug eluting balloon in coronary angioplasty - 12/02/16
Résumé |
Introduction |
Instent restenosis (ISR) remains the weak point of coronary angioplasty despite the advent of drug-eluting stents.The drug eluting balloon (DEB), which in contact of the artery wall releases an antiproliferative agent, could be an option to treat ISR or some de novo lesions.
Methods |
Between October 2013 and December 2014 in our center, all patients treated with DEB for RIS or de novo lesions were identified. ISR was defined as a stenosis of more than 50% or a measuring FFR≤0,8 to a site previously treated by stent. The lesion was first treated by compliant balloon then DEB (SeQuent Please® laboratory Braun® B) was inflated for 30 seconds and then removed. Angiographic control was achieved and, in case of incomplete result or complication, a stent could be implanted.
Results |
Among the 48 patients treated with DEB, 23 were for ISR and 25 for de novo lesions. The average age of patients was 75.7 years. 31% of patients were part of a long-term anticoagulation for atrial fibrillation. The clinical presentation was mostly a stable angina (62%). In 26% of ISR, there was in DES restenosis, the average time of ISR was 2 years±3.9. The average diameter of the DEB used was 2.4mm±0.4 for an average length of 17mm±4.7mm. For five patients (10%) has a complement of stent implantation (DES in 60% of cases). The double antiaggregation was continued during 3.8 months. In-hospital, one death appeared. In the mean follow up of 6.5 months (maximum one year) no deaths were reported. After revascularization 8% of patients had a clinical relapse, 12.5% had a positive ischemic test. In 10.4% of cases, a significant rest-enosis in angioplasty site DEB (TLR) has been highlighted, and requiring a new revascularization.The average period for TLR was 7.6 months±4.
Conclusion |
The DEB is a safe option mainly for ISR and for small caliber arteries, or bifurcation lesions or in the elderly or in long-term anticoagulation. The clinical course is often satisfactory.
Le texte complet de cet article est disponible en PDF.Vol 8 - N° 1
P. 11 - janvier 2016 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?